Д. Петкова, Дихателни нарушения по време на сън: оценка на риска и клиничната ефективност от приложението на неинвазивна вентилация - nCPAP, BiPAP, VPAP в домашни условия, Дисертация за присъждане на образователна и научна степен „доктор“, Варна 2009
Diana Petkova, Yoto Yotov, Dobrin Paskalev, Yana Bocheva, Silva Andonova, Natalia Usheva N-terminal B-type natriuretic peptide (NT-proBNP) in patients with obstructive sleep apnea syndrome , Scripta Scientifica Medica 2011;V.43(1):7-10
BochevaY, Petkova D, Yotov Y, Banova B, Usheva N. Determination of NT-ProBNP in patients with obstructive sleep apnea syndrome. First European Joint Congress of EFCC and UEMS; 13-16 October 2010, Lisbon, Portugal. Book of abstracts,165
. Валентина Димитрова, Дисертационен труд, 2018 г., МУ - Варна
. NT pro BNP прогностичен маркер при пациенти с хронична посттромбоемболична пулмонална хипертония, Димитрова В., Д. Петкова, Й. Йотов, Я. Бочева, Н. Ушева, ИЗВЕСТИЯ НА СЪЮЗА НА УЧЕНИТЕ - ВАРНА 1’2017/ТОМ XXII, 5-11
Доц. Ива Паскалева, д-р Борислав Георгиев, д-р Вера Байчева, доц. Нина Гочева Национална кардиологична болница, Наука Кардиология 2/2010, (65-70) В-натриуретичният пептид в диагностиката на сърдечните заболявания.
Жанета Георгиева, дм. Сърдечно-съдови биомаркери. Монография, 2012.
Дихателни нарушения по време на сън. Кардиоваскуларен риск, Т. Добрева Д. Петкова, В. Стратев, В. Димитрова, П. Атанасов, В. Костадинова, GP NEWS, 2015, 17-20
Aggarwal S, Nadeem R, Loomba RS, et al. The effects of continuous positive airways pressure therapy on cardiovascular end points in patients with sleep-disordered breathing and heart failure: a meta-analysis of randomized controlled trials. Clin Cardiol. 2014;37:57–65.
Al Lawati N, Mulgrew A, Cheema R, et al. Pro-atherogenic cytokine profile of patients with suspected obstructive sleep apnea. Sleep and Breathing. 2009;13(4):391–395. [PubMed]
Alonso-Fernández A, García-Río F, Arias MA, et al. Effects of CPAP on oxidative stress and nitrate efficiency in sleep apnoea: a randomised trial. Thorax. 2009;64(7):581–586. [PubMed]
Arzt M, Harth M, Luchner A, et al. Enhanced ventilatory response to exercise in patients with chronic heart failure and central sleep apnea. Circulation. 2003;107(15):1998-2003 [PubMed]
Arzt M, Young T, Finn L, Skatrud JB, Bradley TD. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med. 2005;172(11):1447–1451
Barceló A, Barbé F, de la Peña M, et al. Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment. European Respiratory Journal. 2006;27(4):756–760. [PubMed]
Barcelo A, Esquinas C, Bauca JM, et al. Effect of CPAP treatment on plasma high sensitivity troponin levels in patients with obstructive sleep apnea. Respir Med. 2014;108:1060–1063.
Belaidi E, Joyeux-Faure M, Ribuot C, Launois SH, Levy P, Godin-Ribuot D. Major role for hypoxia inducible factor-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea. Journal of the American College of Cardiology. 2009;53(15):1309–1317. [PubMed]
Bibbins-Domingo K, Ansari M, Schiller NB, et al. B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study. Circulation. 2003;108:2987–2992.
Bitter T, Westerheide N, Prinz C, et al. Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure. Eur Heart J. 2011;32:61–74. [PubMed]
Bixler EO, Vgontzas AN, Lin HM, et al. Association of hypertension and sleep-disordered breathing. Arch Intern Med. 2000;160(15):2289–95.
Boerrigter G, Costello-Boerrigter LC, Burnett JC, Jr. Natriuretic peptides in the diagnosis and management of chronic heart failure. Heart Fail Clin. 2009;5:501–514.
Botros N, Concato J, Mohsenin V, Selim B, Doctor K, Yaggi HK. Obstructive sleep apnea as a risk factor for type 2 diabetes. Am J Med. 2009;122(12):1122–1127
Bottini P, Dottorini ML, Cordoni MC, Casucci G, Tantucci C. Sleep-disordered breathing in nonobese diabetic subjects with autonomic neuropathy. European Respiratory Journal. 2003;22(4):654–660.
Bradley TD, Floras JS. Sleep apnea and heart failure: part II: central sleep apnea. Circulation. 2003;107(13):1822-1826 [PubMed]
Brooks B, Cistulli PA, Borkman M, et al. Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. Journal of Clinical Endocrinology and Metabolism. 1994;79(6):1681–1685
Brown LK. A waist is a terrible thing to mind: central obesity, the metabolic syndrome, and sleep apnea hypopnea syndrome. Chest. 2002;122(3):774–778. [PubMed]
Calvin AD, Somers VK, van der Walt C, Scott CG, Olson LJ. Relation of natriuretic peptide concentrations to central sleep apnea in patients with heart failure. Chest. 2011;140:1517–23. [PMC free article] [PubMed]
Calvin AD, Somers VK, van der Walt C, Scott CG, Olson LJ. Relation of natriuretic peptide concentrations to central sleep apnea in patients with heart failure. Chest. 2011;140(6):1517-1523
Campo A, Frühbeck G, Zulueta JJ, et al. Hyperleptinaemia, respiratory drive and hypercapnic response in obese patients. Eur Respir J. 2007;30(2):223-231 [PubMed]
Canapari CA, Hoppin AG, Kinane TB, Thomas BJ, Torriani M, Katz ES. Relationship between sleep apnea, fat distribution, and insulin resistance in obese children. Journal of Clinical Sleep Medicine. 2011;7(3):268–273. [PMC free article] [PubMed
Carmona-Bernal C, Quintana-Gallego E, Villa-Gil M, Sánchez-Armengol A, Martínez-Martínez A, Capote F. Brain natriuretic peptide in patients with congestive heart failure and central sleep apnea. Chest. 2005;127(5):1667-1673 [PubMed]
Cassidy AE, Bielak LF, Zhou Y, et al. Progression of subclinical coronary atherosclerosis: does obesity make a difference? Circulation. 2005;111(15):1877–82.
Celec P, Hodosy J, Behuliak M, et al. Oxidative and carbonyl stress in patients with obstructive sleep apnea treated with continuous positive airway pressure. Sleep and Breathing. 2012;16(2):393–398. [PubMed]
Cifci N, Uyar M, Elbek O, et al. Impact of CPAP treatment on cardiac biomarkers and pro-BNP in obstructive sleep apnea syndrome. Sleep Breath. 2010;14:241–244.
Clerico A, Giannoni A, Vittorini S, Emdin M. The paradox of low BNP levels in obesity. Heart Fail Rev. 2012;17(1):81-96
Colish J, Walker JR, Elmayergi N, et al. Obstructive sleep apnea: effects of continuous positive airway pressure on cardiac remodeling as assessed by cardiac biomarkers, echocardiography, and cardiac MRI. Chest. 2012;141:674–681.
Çuhadaroğlu C, Utkusavaş A, Öztürk L, Salman S, Ece T. Effects of nasal CPAP treatment on insulin resistance, lipid profile, and plasma leptin in sleep apnea. Lung. 2009;187(2):75–81
Dan Sorajja, MD,*† Apoor S Gami, MD,*† Virend K Somers, MD, PhD,*† Thomas R Behrenbeck, MD, PhD,*† Arturo Garcia-Touchard, MD,*† and Francisco Lopez-Jimenez, MD*†. Independent Association Between Obstructive Sleep Apnea and Subclinical Coronary Artery Diseasе. Chest. 2008 April; 133(4): 927–933.
Dean RT1, Wilcox I. Possible atherogenic effects of hypoxia during obstructive sleep apnea.Sleep. 1993 Dec;16(8 Suppl):S15-21; discussion S21-2
Dematteis M, Julien C, Guillermet C, et al. Intermittent hypoxia induces early functional cardiovascular remodeling in mice. Am J Respir Crit Care Med. 2008;177(2):227–235. [PubMed]
Drager LF, Jun J, Polotsky VY. Obstructive sleep apnea and dyslipidemia: implications for atherosclerosis [published correction appears in Curr Opin Endocrinol Diabetes Obes. 2010;17(4):394] Curr Opin Endocrinol Diabetes Obes. 2010;17(2):161–165.
Drager LF, Jun JC, Polotsky VY. Metabolic consequences of intermittent hypoxia: relevance to obstructive sleep apnea. Best Pract Res Clin Endocrinol Metab. 2010;24(5):843–851.
Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. The American Journal of Respiratory and Critical Care Medicine. 2002;165(7):934–939. [PubMed]
Einvik G, Rosjo H, Randby A, et al. Severity of obstructive sleep apnea is associated with cardiac troponin I concentrations in a community-based sample: data from the Akershus Sleep Apnea Project. Sleep. 2014;37:1111–1116, 1116A–1116B.
Elmasry A, Lindberg E, Berne C, et al. Sleep-disordered breathing and glucose metabolism in hypertensive men: a population-based study. Journal of Internal Medicine. 2001;249(2):153–161
Fain JN, Kanu A, Bahouth SW, Cowan GSM, Lloyd Hiler M. Inhibition of leptin release by atrial natriuretic peptide (ANP) in human adipocytes. Biochem Pharmacol. 2003;65(11):1883-1888 [PubMed]
Fasshauer M, Kralisch S, Klier M, et al. Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications. 2003;301(4):1045–1050. [PubMed]
Fletcher EC, Lesske J, Qian W, Miller CC, III, Unger T. Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. Hypertension. 1992;19(6 Pt 1):555–561. [PubMed
Franklin KA, Nilsson JB, Sahlin C, et al. Sleep apnoea and nocturnal angina. Lancet. 1995;345:1085–1087.
Gami AS, Howard DE, Olson EJ, et al. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med. 2005;352(12):1206–14. [PubMed]
Gami AS, Pressman G, Caples SM, et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation. 2004;110:364–367.
Gami AS, Pressman G, Caples SM, Kanagala R, Gard JJ, Davison DE, et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation. 2004;110(4):364–367
Gasa M, Salord N, Fortuna AM, et al. Obstructive sleep apnoea and metabolic impairment in severe obesity. European Respiratory Journal. 2011;38(5):1089–1097. [PubMed]
Goetze JP, Friis-Hansen L, Rehfeld JF, et al. Atrial secretion of B-type natriuretic peptide. Eur Heart J. 2006;27:1648–1650.
Grote L, Ploch T, Heitmann J, et al. Sleep-related breathing disorder is an independent risk factor for systemic hypertension. Am J Respir Crit Care Med. 1999;160(6):1875–82. [PubMed]
Hall C. Essential biochemistry and physiology of (NT-pro)BNP. Eur J Heart Fail. 2004;6:257–260.
Hall MJ, Xie A, Rutherford R, Ando S, Floras JS, Bradley TD. Cycle length of periodic breathing in patients with and without heart failure. Am J Respir Crit Care Med. 1996;154:376–81. [PubMed]
Hanly P, Sasson Z, Zuberi N, et al. ST-segment depression during sleep in obstructive sleep apnea. Am J Cardiol. 1993;71:1341–1345.
Hanly P, Zuberi N, Gray R. Pathogenesis of Cheyne-Stokes respiration in patients with congestive heart failure: relationship to arterial PCO2. Chest. 1993;104:1079–84. [PubMed]
Hanly P, Zuberi-Khokhar N. Daytime sleepiness in patients with congestive heart failure and Cheyne-Stokes respiration. Chest. 1995;107:952–8. [PubMed]
Harsch IA, Koebnick C, Wallaschofski H, et al. Resistin levels in patients with obstructive sleep apnoea syndrome—the link to subclinical inflammation? Medical Science Monitor. 2004;10(9):CR510–CR515.79
Harsch IA, Konturek PC, Koebnick C, et al. Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. European Respiratory Journal. 2003;22(2):251–257.
Hoff JA, Daviglus ML, Chomka EV, et al. Conventional coronary artery disease risk factors and coronary artery calcium detected by electron beam tomography in 30,908 healthy individuals. Ann Epidemiol. 2003;13(3):163–9. [PubMed]
Hubner RH, El Mokhtari NE, Freitag S, et al. NT-proBNP is not elevated in patients with obstructive sleep apnoea. Respir Med. 2008;102:134–142.
Ip MS, Tse HF, Lam B, Tsang KW, Lam WK. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med. 2004;169(3):348–353. [PubMed]
Ip MSM, Lam KSL, Ho C, Tsang KWT, Lam W. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest. 2000;118(3):580–586
Isono S. Obstructive sleep apnea of obese adults: pathophysiology and perioperative airway management. Anesthesiology. 2009;110(4):908–921. [PubMed
January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC, Jr, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines 2014 AHA/ACC/HRS Guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64(21):e1–76. Erratum in: J Am Coll Cardiol. 2014;64(21):2305-7
Javaheri S, Dempsey JA. Central sleep apnea. Compr Physiol. 2013;3:141–63. [PubMed]
Javaheri S, Parker TJ, Liming JD, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation. 1998;97:2154–9. [PubMed]
Javaheri S, Parker TJ, Liming JD, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation. 1998;97:2154–9. [PubMed]
Javaheri S, Parker TJ, Liming JD, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation. 1998;97(21):2154-2159 [PubMed]
Javaheri S. A mechanism of central sleep apnea in patients with heart failure. N Engl J Med. 1999;341:949–54. [PubMed]
Javaheri S. A mechanism of central sleep apnea in patients with heart failure. N Engl J Med. 1999;341(13):949-954.
Javaheri S. Sleep disorders in systolic heart failure: a prospective study of 100 male patients. The final report. Int J Cardiol. 2006;106:21–8. [PubMed]
Jun J, Polotsky VY. Metabolic consequences of sleep-disordered breathing. ILAR J. 2009;50(3):289–306. [PubMed]
Kaditis AG, Alexopoulos EI, Hatzi F, et al. Overnight change in brain natriuretic peptide levels in children with sleep-disordered breathing. Chest. 2006;130:1377–1384.
Kapsimalis F, Varouchakis G, Manousaki A, et al. Association of sleep apnea severity and obesity with insulin resistance, C-reactive protein, and leptin levels in male patients with obstructive sleep apnea. Lung. 2008;186(4):209–217.
Kita H, Ohi M, Chin K, et al. The nocturnal secretion of cardiac natriuretic peptides during obstructive sleep apnoea and its response to therapy with nasal continuous positive airway pressure. J Sleep Res. 1998;7:199–207.
Kraiczi H, Peker Y, Caidahl K, et al. Blood pressure, cardiac structure and severity of obstructive sleep apnea in a sleep clinic population. J Hypertens. 2001;19(11):2071–8. [PubMed]
Krapalis AF, Reiter J, Machleidt F, et al. Ghrelin modulates baroreflex-regulation of sympathetic vasomotor tone in healthy humans. The American Journal of Physiology. 2012;302(11):R1305–R1312.
Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ. 2000;320(7233):479–82. [PMC free article] [PubMed]
Li J, Savransky V, Nanayakkara A, Smith PL, O’Donnell CP, Polotsky VY. Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia. J Appl Physiol. 2007;102(2):557–563.
Lindahl B, Toss H, Siegbahn A, et al. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med. 2000;343:1139–1147.
Lonn E, Bosch J, Yusuf S, et al. HOPE and HOPE-TOO Trial Investigators Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA. 2005;293(11):1338–1347. [PubMed]
Lorenzi-Filho G, Azevedo ER, Parker JD, Bradley TD. Relationship of carbon dioxide tension in arterial blood to pulmonary wedge pressure in heart failure. Eur Respir J. 2002;19:37–40. [PubMed]
Louis M, Punjabi NM. Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. J Appl Physiol. 2009;106(5):1538–1544. [PMC free article] [PubMed]
Luciano F. Drager, MD, PhD, Vsevolod Y. Polotsky, MD, PhD, and Geraldo Lorenzi-Filho, MD, PhDcorresponding authorObstructive Sleep Apnea. An Emerging Risk Factor for Atherosclerosis.Chest. 2011 Aug; 140(2): 534–542.
MacDonald M, Fang J, Pittman SD, et al. The current prevalence of sleep disordered breathing in congestive heart failure patients treated with beta-blockers. J Clin Sleep Med. 2008;4:38–42. [PMC free article] [PubMed]
Macrea M, Martin T, Zagrean L, Jia Z, Misra H. Role of leptin as antioxidant in obstructive sleep apnea: an in vitro study using electron paramagnetic resonance method. Sleep and Breathing. 2013;17(1):105–110.
Maeder MT, Strobel W, Christ M, Todd J, Estis J, Wildi K, Thalmann G, Hilti J, Brutsche M, Twerenbold R, Rickli H, Mueller C. Comprehensive biomarker profiling in patients with obstructive sleep apnea. Clin Biochem. 2015 Mar;48(4-5):340-6. doi: 10.1016/j.clinbiochem.2014.09.005. Epub 2014 Sep 16.
Makino S, Handa H, Suzukawa K, et al. Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance. Clinical Endocrinology. 2006;64(1):12–19. [PubMed]
Makinodan K, Yoshikawa M, Fukuoka A, et al. Effect of serum leptin levels on hypercapnic ventilatory response in obstructive sleep apnea. Respiration. 2008;75(3):257-264 [PubMed]
Malakasioti G, Alexopoulos E, Befani C, et al. Oxidative stress and inflammatory markers in the exhaled breath condensate of children with OSA. Sleep and Breathing. 2012;16(3):703–708. [PubMed]
Malli F, Papaioannou AI, Gourgoulianis KI, Daniil Z. The role of leptin in the respiratory system: an overview. Respir Res. 2010;11(1):152. [PMC free article] [PubMed]
Аmerican Academy of Sleep Medicine, International Classification of Sleep Disorders, 3-rd ed. Darien, II, 2014.
